Investing in the next generation of high-growth businesses

We are the growth equity division of Gresham House, working with exceptional entrepreneurs to take their business to the next level.

We are always on the look out for young businesses with exciting potential. We specialise in scaling companies across a diversified range of sectors, including healthcare & education, consumer markets, technology & communications, and business services.

£1mn-£20mn

Investment size

200+

Investments

20yr

Track record

£200mn

Capital to invest

Mable Therapy

Leading digital health platform for children’s speech and language therapy and counselling services

Dayrize

Sustainability impact software business

Cognassist

Research-based neuroinclusion solutions

Connect Earth

Climate impact data company

FocalPoint

High performance positioning technologies

Orri

Eating disorder clinics offering virtual and in-person services

The Masters Removers Group

Specialist logistics, storage and removals businesses

SEC Life Sciences

A leading provider of talent acquisition services within the field of life sciences

Veritek

Field engineering service partnerships that empower OEMs to scale after-sales service capacity

See our portfolio

Gresham House Ventures’ longstanding experience in the digital healthcare space makes it the ideal partner

Kerrie Jones, CEO, Orri

Gresham House Ventures are a natural partner as the team bring a wealth of experience scaling B2B SaaS… the team intuitively understands the pressures retailers face.

Liam Patterson, CEO and Co-founder, Bidnamic

From the outset, it was clear Gresham House Ventures shared our belief in the critical role technology will play in supporting the new era of retail. The team’s combined expertise and proven track-record in scaling software specialists will be fundamental to unlocking our next phase of growth.

Cathy McCabe, Founder & CEO, Proximity

The Gresham House Ventures team’s focus on personalisation within e-commerce makes them a natural fit for us. This investment will help us expand Popsa’s presence internationally and deepen our understanding of the wealth of data in photos.

Liam Houghton, CEO, Popsa

This new investment is a key part of Metrion’s strategic development, enabling the Company to expand its laboratories, provide enhanced services and invest more extensively in US business development. We thank Gresham House for the confidence they have shown in the Metrion team.

Keith McCullagh, Chairman, Metrion Biosciences